Search Results - richard+johnson

3 Results Sort By:
Multicolor SYNGAP1 Alternative Splice Reporters
Value Proposition·        High sensitivity: detection of specific splicing events ·        High throughput: can assess multiple splicing scenarios due to tri-chromatic and tetra-chromatic reporter plasmids ·        Improved SYNGAP1 treatment research·        Reduced time to assess candidate treatments Technology DescriptionResearchers at Johns Hopkins...
Published: 3/14/2025   |   Inventor(s): Ingie Hong, Richard Huganir, Yoichi Araki, Richard Johnson
Keywords(s):  
Category(s): Technology Classifications > Research Tools > Vectors & Plasmids, Clinical and Disease Specializations > Psychiatry > Autism Spectrum Disorder, Clinical and Disease Specializations > Psychiatry > Schizophrenia
SYNGAP1 splice-switching antisense oligonucleotide as therapy for human cognitive disorders
Unmet Need: SYNGAP1-related Intellectual Disability (SRID, MRD5) is a severe neurodevelopmental disorder (NDD) characterized by encephalopathy, intellectual disability (ID), autism spectrum disorder (ASD), and epilepsy and accounts for 0.5-1% of all NDDs and ~1% of the ~200 million ID cases worldwide (SYNGAP Research Fund, 2020). Supportive management...
Published: 3/14/2025   |   Inventor(s): Richard Huganir, Yoichi Araki, Ingie Hong, Richard Johnson, Yinuo Han
Keywords(s):  
Category(s): Technology Classifications > Research Tools > Vectors & Plasmids
Gene therapy for SYNGAP1 encephalopathy and SYNGAP1-related disorders
Unmet Need: SYNGAP1-related Intellectual Disability (SRID, MRD5) is a severe neurodevelopmental disorder (NDD) characterized by encephalopathy, intellectual disability (ID), autism spectrum disorder (ASD), and epilepsy and accounts for 0.5-1% of all NDDs and ~1% of the ~200 million ID cases worldwide (SYNGAP Research Fund, 2020). Supportive management...
Published: 3/14/2025   |   Inventor(s): Richard Huganir, Ingie Hong, Yoichi Araki, Richard Johnson
Keywords(s):  
Category(s): Clinical and Disease Specializations > Rare Diseases, Clinical and Disease Specializations > Neurology, Technology Classifications > Therapeutic Modalities > Gene Therapies
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum